Choroidal detachment

H7_CHORDETACH

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 H31.4
  • Hospital discharge: ICD-9 3637
  • Hospital discharge: ICD-8 3785
  • Cause of death: ICD-10 H31.4
  • Cause of death: ICD-9 3637
  • Cause of death: ICD-8 3785

2 out of 7 registries used, show all original rules.

96

4. Check minimum number of events

None

96

5. Include endpoints

None

96

6. Filter based on genotype QC (FinnGen only)

88

Control definitions (FinnGen only)

Control exclude
H7_CHOROIDRETINA

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H31
Name in latin
Ablatio chorioideae

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 799 431 358
Only index persons 630 346 284
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 73.78 76.13 70.93
Only index persons 73.34 76.49 69.51

-FinnGen-

Key figures

All Female Male
Number of individuals 88 40 48
Unadjusted period prevalence (%) 0.02 0.01 0.02
Median age at first event (years) 71.77 71.23 72.22

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
93
Matched controls
930
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H31.4
ICD-10 Finland
Choroidal detachment
+∞
123.5
89
*
S01ED51
ATC
timolol, combinations; ophthalmic
32.0
66.9
60
50
114
Kela drug reimbursment
Glaucoma
18.9
47.9
55
66
Z96.1
ICD-10 Finland
Presence of intraocular lens
16.0
41.6
64
113
S01ED01
ATC
timolol; ophthalmic
19.0
35.0
32
25
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
18.9
34.0
31
24
S01EE01
ATC
latanoprost; ophthalmic
15.1
33.9
37
39
S01EA05
ATC
brimonidine; ophthalmic
41.7
30.7
38
15
S01EC01
ATC
acetazolamide; systemic
52.1
30.7
36
11
XCK00
NOMESCO Finland
Perimetry
13.6
26.4
29
30
CHD65
NOMESCO Finland
Nonpenetrating glaucoma surgery
79.6
22.1
24
*
H40.10
ICD-10 Finland
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
27.0
21.8
30
16
XCW99
NOMESCO Finland
Other investigative procedure of eye
10.9
20.7
26
32
H33.0
ICD-10 Finland
Retinal detachment with retinal break
+∞
20.6
19
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
10.2
20.3
27
36
S01EX03, ,
ATC
32.2
20.0
26
11
S01EC04
ATC
brinzolamide; ophthalmic
22.8
20.0
29
18
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
9.5
18.5
78
330
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
+∞
18.3
17
*
S01EC03
ATC
dorzolamide; ophthalmic
33.3
18.0
23
9
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
7.1
17.6
69
269
WX140
NOMESCO Finland
Parabulbar anesthesy
26.4
17.6
24
12
XCK10
NOMESCO Finland
Photography of fundus of eye
7.2
14.3
25
45
S01EE03
ATC
bimatoprost; ophthalmic
38.1
13.1
16
5
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
149.3
12.8
13
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
5.4
12.6
32
82
CHD00
NOMESCO Finland
Laser trabeculoplasty
35.3
12.1
15
5
S01EE05
ATC
tafluprost; ophthalmic
12.6
11.8
21
21
CHD50
NOMESCO Finland
Shunt operation on anterior chamber
+∞
11.7
11
*
CHC05
NOMESCO Finland
Iridotomy
29.4
11.6
15
6
S01EE04
ATC
travoprost; ophthalmic
29.4
11.6
15
6
S01EA03
ATC
apraclonidine; ophthalmic
32.5
11.1
14
5
S01EC54
ATC
brinzolamide, combinations; ophthalmic
32.5
11.1
14
5
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
68.0
10.9
12
*
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
15.7
10.7
17
13
CJB10
NOMESCO Finland
Laser discission of secondary cataract
5.3
10.1
24
57
CHD99
NOMESCO Finland
Other filtering operation
61.6
9.9
11
*
CHD35
NOMESCO Finland
Laser goniopuncture
110.8
9.6
10
*
CHD15
NOMESCO Finland
Trabeculectomy and iridectomy
41.1
9.2
11
*
XCH00
NOMESCO Finland
Eye pressure measurement
9.4
8.9
18
23
H25.1
ICD-10 Finland
Senile nuclear cataract
3.6
8.5
57
283
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
+∞
8.5
8
*
H57.1
ICD-10 Finland
Ocular pain
13.5
8.4
14
12
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
13.5
8.4
14
12
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
3.6
8.1
60
314
H26.4
ICD-10 Finland
After-cataract
4.4
8.1
24
68
CHD10
NOMESCO Finland
Trabeculectomy
+∞
7.4
7
*
H20.1
ICD-10 Finland
Chronic iridocyclitis
+∞
7.4
7
*
S01BA07
ATC
fluorometholone; ophthalmic
32.8
7.3
9
*
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
43.3
6.9
8
*
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
19.7
6.4
9
5
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
28.8
6.3
8
*
S01EB01
ATC
pilocarpine; ophthalmic
28.8
6.3
8
*
3708
FHL
Trabeculectomy or equivalent
+∞
6.3
6
*
H35.36
ICD-10 Finland
Macular cyst
+∞
6.3
6
*
H40.0
ICD-10 Finland
Glaucoma suspect
4.3
6.3
18
49
H16.0
ICD-10 Finland
Corneal ulcer
9.6
6.3
12
14
S01BC05
ATC
ketorolac; ophthalmic
6.0
6.0
16
31
S01ED02
ATC
betaxolol; ophthalmic
16.4
6.0
9
6
S01BC03
ATC
diclofenac; ophthalmic
16.4
6.0
9
6

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
51
341
2.10
3.05
5.2
4.5
0.00
0.00
estimate
-0.00
14
73
29
156
2.25
3.02
2.9
3.5
559.82
524.21
mosm/kgh2o
0.29
24
137
51
346
2.05
2.89
5.1
4.6
0.00
21.65
estimate
0.49
14
75
51
348
2.03
2.82
5.2
4.7
0.00
0.00
estimate
-0.00
13
71
6
12
5.26
2.44
1.2
1.4
—
—
—
0
0
21
109
2.20
2.34
3.1
6.2
7.40
7.41
ph
0.13
14
69
15
69
2.40
2.18
1.6
1.6
—
—
—
0
0
37
248
1.82
1.99
4.3
3.6
—
—
—
0
0
41
285
1.78
1.95
5.2
4.3
97.69
124.01
e6/l
0.14
30
200
38
259
1.79
1.93
4.3
3.5
20.83
299.88
e6/l
0.56
28
193
20
110
2.04
1.92
3.2
6.2
0.29
0.94
mmol/l
0.23
11
86
37
252
1.78
1.87
5.8
4.7
0.00
0.03
estimate
—
10
58
51
382
1.74
1.85
6.5
7.5
1.20
1.21
mmol/l
0.60
45
335
57
446
1.72
1.72
6.3
5.3
—
4291.85
—
0
13
7
25
2.94
1.68
4.4
3.2
—
—
—
0
0
58
461
1.69
1.61
4.6
4.7
15.03
15.30
pmol/l
0.40
51
410
22
134
1.84
1.57
4.1
3.2
0.73
2.48
e6/l
—
10
64
38
275
1.65
1.48
3.4
4.1
6.25
6.21
ph
0.06
18
149
28
187
1.71
1.47
5.5
4.1
0.00
0.04
estimate
—
9
56
32
227
1.62
1.33
4.2
3.4
0.07
0.44
e6/l
2.86
22
158
5
20
2.58
1.16
3.6
3.3
7.35
7.42
ph
—
5
20
32
234
1.56
1.16
1.9
2.2
—
—
—
0
0
7
31
2.36
1.13
1.6
5.0
—
—
—
0
0
30
219
1.55
1.09
5.6
5.2
—
—
—
0
0
10
54
1.95
1.01
4.1
7.1
92.19
94.02
%
—
10
54
46
373
1.46
0.99
11.7
10.0
4.24
4.36
e9/l
0.15
41
324
38
298
1.47
0.97
2.7
2.5
—
—
estimate
—
0
0
31
235
1.48
0.93
4.7
4.5
—
—
—
0
0
66
579
1.48
0.91
4.9
5.3
4.49
4.35
mmol/l
0.31
58
527
26
191
1.50
0.90
6.6
4.8
0.00
0.00
estimate
—
10
63
8
43
1.94
0.90
1.6
1.4
—
—
—
0
0
41
332
1.42
0.87
8.1
6.2
0.17
0.19
e9/l
0.59
36
286
10
58
1.81
0.83
1.8
1.5
—
—
—
0
0
6
32
1.93
0.83
2.2
2.3
—
—
—
0
0
40
326
1.40
0.80
8.2
6.0
0.60
0.63
e9/l
0.32
33
279
21
152
1.49
0.78
1.8
1.8
1092.93
1128.83
nmol/l
0.05
12
115
22
161
1.48
0.78
3.3
3.0
2.46
2.47
mmol/l
0.16
17
143
40
328
1.39
0.77
7.7
5.9
0.04
0.04
e9/l
0.01
33
279
10
60
1.75
0.75
2.9
3.7
—
—
—
0
0
32
254
1.40
0.74
3.4
5.1
7.38
7.39
ph
0.77
20
176
9
58
1.61
0.72
1.2
3.4
—
—
—
0
0
14
94
1.58
0.72
1.1
1.3
18.05
10.82
u/ml
—
6
26
7
41
1.76
0.72
8.0
4.4
36.87
36.92
°c
—
7
41
22
164
1.45
0.71
2.1
1.9
506.07
458.89
pmol/l
0.21
14
135
64
571
1.39
0.71
6.0
5.7
1.69
2.06
mu/l
2.36
58
505
64
574
1.37
0.66
4.6
5.3
1.41
1.43
mmol/l
0.15
57
518
17
122
1.48
0.66
5.2
6.1
104.18
103.82
mmol/l
0.12
17
122
19
140
1.45
0.65
1.2
1.2
0.77
4.11
u/ml
—
7
35
13
89
1.54
0.62
1.2
1.2
—
—
—
0
0
38
319
1.32
0.60
6.2
5.1
47.70
44.87
ng/l
0.07
28
251
26
206
1.36
0.60
4.3
2.5
57.12
77.22
u/l
0.44
26
193
64
579
1.34
0.59
7.9
7.2
41.91
41.00
mmol/mol
0.26
59
532
5
90
0.53
0.59
1.6
1.4
—
—
—
0
0
9
59
1.58
0.57
5.0
2.8
1.14
1.17
%
—
9
59
39
331
1.31
0.57
2.4
2.3
97.13
94.76
pmol/l
0.11
20
164
6
37
1.66
0.57
1.5
2.9
—
—
—
0
0
36
303
1.31
0.55
8.6
5.7
0.67
0.63
%
0.22
31
283
20
155
1.37
0.52
3.4
4.0
14.87
306.87
ng/l
1.14
15
139
65
595
1.31
0.51
6.3
6.3
2.68
2.48
mmol/l
0.68
58
542
27
222
1.30
0.48
2.4
2.3
—
—
—
0
0
5
81
0.60
0.48
2.2
1.3
—
—
—
0
0
8
57
1.44
0.43
5.4
2.8
0.54
0.68
%
—
8
57
8
57
1.44
0.43
1.9
1.4
—
—
—
0
0
67
622
1.28
0.43
25.2
19.7
26.95
27.10
mg/l
0.01
54
527
29
245
1.27
0.42
6.4
5.0
1.38
2.60
ug/l
1.35
24
212
16
124
1.35
0.42
1.4
1.3
2.24
2.53
g/l
—
9
62
5
33
1.54
0.42
5.6
3.2
28.00
61.40
u/ml
—
5
33
0
17
0.00
0.41
0.0
2.2
—
59.64
—
0
17
34
297
1.23
0.37
20.0
12.3
0.00
0.00
e9/l
0.49
27
246
6
41
1.49
0.37
1.3
1.3
—
—
—
0
0
67
628
1.24
0.36
20.6
17.0
—
—
—
0
0
29
251
1.23
0.34
3.3
3.8
16.83
8.00
mg/mmol
0.27
16
165
7
51
1.40
0.32
4.7
4.3
24.67
24.65
mmol/l
—
7
51
58
545
1.17
0.26
4.2
4.5
1.32
1.25
mmol/l
0.28
52
489
69
658
1.19
0.25
36.4
29.8
129.49
130.93
g/l
0.29
69
643
27
240
1.18
0.24
3.0
3.2
92.03
46.11
mg/l
0.27
18
168
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
0
11
0.00
0.21
0.0
5.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
6442.00
—
0
5
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
6
47
1.30
0.21
1.8
1.3
—
—
—
0
0
6
47
1.30
0.21
1.5
1.1
—
—
—
0
0
6
48
1.27
0.21
2.0
1.5
—
—
—
0
0
15
128
1.20
0.20
8.7
6.9
—
—
—
0
0
6
52
1.16
0.19
7.0
4.5
—
—
—
0
0
24
215
1.16
0.19
10.6
6.7
—
—
—
0
0
7
57
1.25
0.19
6.6
3.3
—
—
—
0
0
9
79
1.15
0.16
7.7
7.2
—
—
—
0
0
17
153
1.14
0.12
1.5
1.3
—
—
—
0
0
21
192
1.12
0.12
2.2
3.6
—
—
—
0
0
5
61
0.81
0.08
1.4
1.3
—
—
—
0
0
11
98
1.14
0.08
1.5
1.7
—
—
—
0
0
8
73
1.10
0.08
1.5
1.2
—
—
—
0
0
10
108
0.92
0.03
7.9
5.1
1.26
1.04
mmol/l
—
10
100
13
123
1.07
0.02
1.0
1.9
29.73
29.54
s
0.07
13
118
11
104
1.07
0.01
1.5
1.3
28.83
41.43
iu/ml
—
6
34
14
142
0.98
0.00
3.1
3.2
0.54
0.90
ug/l
—
7
97
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
4.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.3
—
57.00
—
0
6
0
6
0.00
-0.00
0.0
1.8
—
0.83
—
0
6
6
62
0.97
-0.00
1.3
2.4
0.20
0.20
g/l
—
6
56
0
6
0.00
-0.00
0.0
1.8
—
11.35
—
0
6
0
7
0.00
-0.00
0.0
1.6
—
0.67
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
67
0.89
-0.00
9.2
2.9
3.71
8.26
e9/l
—
6
57
0
8
0.00
-0.00
0.0
1.0
—
25.38
—
0
8
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
203.33
—
0
9

Mortality – FinRegistry

Association

Association between endpoint H7_CHORDETACH and mortality.

Females

Parameter HR [95% CI] p-value
H7_CHORDETACH 0.994 [0.82, 1.21] 0.953
Birth year 0.994 [0.99, 1.0] 0.199

During the follow-up period (1.1.1998 — 31.12.2019), 151 out of 331 females with H7_CHORDETACH died.

Males

Parameter HR [95% CI] p-value
H7_CHORDETACH 0.9 [0.7, 1.15] 0.399
Birth year 0.987 [0.98, 1.0] 0.01

During the follow-up period (1.1.1998 — 31.12.2019), 108 out of 260 males with H7_CHORDETACH died.

Mortality risk

Mortality risk for people of age

years, who have H7_CHORDETACH.

N-year risk Females Males
1 0.071% 0.169%
5 0.545% 0.93%
10 1.404% 2.5%
15 2.849% 5.043%
20 4.983% 8.75%

Relationships between endpoints

Index endpoint: H7_CHORDETACH – Choroidal detachment

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data